Literature DB >> 9041244

Cytokines modulate fibroblast phenotype and epithelial-stroma interactions in rat intestine.

C Fritsch1, P Simon-Assmann, M Kedinger, G S Evans.   

Abstract

BACKGROUND & AIMS: Homeostasis of the intestinal epithelium depends on interactions with the underlying connective tissue that may be altered during the pathogenesis of disease. The aim of this study was to establish whether fibroblast phenotype can influence morphogenesis and differentiation of the gut epithelium.
METHODS: Permanently growing, nontumorigenic, homogenous fibroblast lines were established from postnatal rat intestinal mucosa. Their phenotypic characterization included their growth response to cytokines and expression of cytoskeletal and membrane markers, as well as expression of basement membrane components, laminin 1 and collagen IV. Their influence on epithelial growth, functional polarization, and morphogenesis was analyzed using coculture and tissue grafting of the fibroblast lines with fetal gut endoderm.
RESULTS: Two intestinal fibroblast lines are described, one that supports normal intestinal morphogenesis and differentiation, and one that induces growth of fetal epithelial cells. Among the phenotypic differences between the two lines, the former differentiates into myofibroblasts in response to transforming growth factor beta1 and, in basal conditions, expresses twice as much laminin than the latter. The growth of the two lines is also affected differentially by transforming growth factor beta1 and interleukin 2.
CONCLUSIONS: Cytokines, which are expressed in association with inflammation, regulate fibroblast differentiation. Fibroblasts may modify the function and organization of the overlying intestinal epithelium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041244     DOI: 10.1053/gast.1997.v112.pm9041244

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

Review 1.  Myofibroblasts: paracrine cells important in health and disease.

Authors:  D W Powell
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

Review 2.  Homeobox genes in gut development.

Authors:  F Beck
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 3.  Fistulising Crohn's disease: MMPs gone awry.

Authors:  D Schuppan; T Freitag
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 4.  Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response.

Authors:  Akira Andoh; Shigeki Bamba; Yoshihide Fujiyama; Mairi Brittan; Nicholas A Wright
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

Review 5.  Wound healing and fibrosis in intestinal disease.

Authors:  F Rieder; J Brenmoehl; S Leeb; J Schölmerich; G Rogler
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

Review 6.  The possible role of isolated lymphoid follicles in colonic mucosal repair.

Authors:  Ferenc Sipos; Györgyi Muzes; Orsolya Galamb; Sándor Spisák; Tibor Krenács; Kinga Tóth; Zsolt Tulassay; Béla Molnár
Journal:  Pathol Oncol Res       Date:  2009-06-26       Impact factor: 3.201

Review 7.  Cellular and molecular partners involved in gut morphogenesis and differentiation.

Authors:  M Kedinger; O Lefebvre; I Duluc; J N Freund; P Simon-Assmann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

8.  Isolated lymphoid follicles in colon: switch points between inflammation and colorectal cancer?

Authors:  Ferenc Sipos; Györgyi Muzes
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

Review 9.  The alpha-smooth muscle actin promoter: a useful tool to analyse autocrine and paracrine roles of mesenchymal cells in normal and diseased bowel.

Authors:  P K Lund
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

Review 10.  Growth control mechanisms in normal and transformed intestinal cells.

Authors:  A W Burgess
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.